Nanomedicine and Drug Delivery

About Conference

Nanotechnology is the improvement and engineering of devices so small that they are measured on a molecular scale. This developing field involves scientists from many different disciplines, including physicists, chemists, engineers, information technologists, and material Researchers, as well as biologists. Nanotechnology is being applied to almost every field imaginable, including electronics, magnetics, information technology, materials development and biomedicine. There are numerous areas of concern in the Nano science and nanotechnology market which are expectable to be explored in the approaching years, for instance, nanoparticles of metals and semi conductors, nanowires, nano biological systems and nanotubes,. Nano medicine and Drug Delivery  Conference greetings attendees, presenters, & exhibitors from all over the world to Perth, Australia. We are delighted to invite you all to join & register for the international conference on “5th Annual Congress on Nano medicine and Drug Delivery" which is going to be organized during August 10-11, 2020 in Bangkok, Thailand.

Importance & Scope:

Nano technology is growing as a several purpose technology with potential applications in many sectors of the global economy, in addition to healthcare, consumer products, energy and agriculture among others. It is often seen as a new industrial revolution, and is incrementally attracting worldwide attention owing to its wide range of end-uses. Nano technology has huge development prospects owing to a wide range of potential products & applications, and there is an enormous scope for its commercial extension. The global nanotechnology market is expected to grow at a CAGR of around 17.5% during 2016-2022. Thus, there lies a huge chance for industry participants to tap the fast growing market. In the newest research survey, ‘Global Nanotechnology Market Outlook 2022’ the analyst have conducted a segmented research of the nanotechnology industry and have explicate the key market trends to clearly highlight the areas offering promising possibilities for industries to boost their development. In 2015, the global nanotechnology market has shown impressive development supported by certain prominent factors, like acquiring significant amounts of public and private investments in R&D, partnerships & strategic alliances between the countries. At present, the bio-medical industry is one of the largest sectors in which Nano-enabled products have made crucial contributions, majorly in healthcare industry, with significant growth being done in other topics like electronics and energy as well. In this report, the analysts have considered the present nanotechnology marketplace on segment basis (by application, by component and by region), while covering the present market scenario as well as contributing forecasts for each of the indicated segments till 2021. The report covers an in-depth analysis of all the important segments, taking into account the key growth taking place at global level, like creations of new opportunities by different countries for nano technology industry to develop products in divergent verticals and the emergence of advanced markets that can impel the growth of Nano science and Nano technology.  The global market for the nano material's in the year 2006 was around US $14,000, and the global investments are to be increased 50% more by the ending of 2020.

Why to attend?

With members from around the world focused on learning about Nano science and Nano technology, this is your single best opportunity to reach the largest assemblage of participants from all over the world. Conduct demonstrations, distribute information, meet with current and potential customers, make a splash with a new product line, and receive name recognition at this 2-day event.

World-renowned speakers, the most recent techniques, tactics, and the newest updates in fields Nano science and technology, Materials and molecular nano technology, tissue engineering are hallmarks of this conference.

Nanotechnology Research Worldwide:

Nanotechnology has been heralded as having the potential to lead to the next industrial revolution. Nanotechnology is one of the top-ranked subjects in the academic and research field. It is an enabling technology which generates new capabilities, products and markets and so on. The global market for nano technology products was valued at $22.9 billion in 2013 and increased to about $26 billion in 2014. This market is expected to reach about $64.2 billion by 2019; a compound annual growth rate (CAGR) of 19.8% from 2014 to 2019.The global market for nano technology-enabled printing technology was estimated to total $14 billion in 2013. The market is expected to grow at a projected compound annual growth rate (CAGR) of 17.7% over the next five years to total $31.8 billion by 2021.

Market Growth of Nano science and Nano technology Research in the last and upcoming ten years:

Nano technology is a rapidly growing technology with potential applications in many sectors of global economy, namely healthcare, cosmetics, energy, and agriculture among others. The technology is revolutionizing every industry, while tremendously attracting worldwide attention. Owing to its wide range of uses, the global nano technology market is expected to grow at a CAGR of around 17% during the forecasted period of 2018-2024. Thus, there lies a great opportunity for industry participants to tap the fast growing market, which would garner huge revenue on the back of commercialization of the technology.

Nano technology is a rapidly growing technology with potential applications in many sectors of global economy, namely healthcare, cosmetics, energy, and agriculture among others. The technology is revolutionizing every industry, while tremendously attracting worldwide attention. Owing to its wide range of uses, the global nano technology market is expected to grow at a CAGR of around 17% during the forecasted period of 2018-2024. Thus, there lies a great opportunity for industry participants to tap the fast growing market, which would garner huge revenue on the back of commercialization of the technology.

market trends & developments that clearly highlight the areas offering promising possibilities for industries to boost their growth. In 2017, the global nano technology market has shown impressive growth owing to factors, like increase in government and private sector funding for R&D, partnerships & strategic alliances between countries, and increased in demand for smaller and more powerful devices at affordable prices. At present, the healthcare industry is one of the largest sectors where nanotechnology has made major breakthrough with its application for the diagnosis and treatment of chronic diseases like cancer, heart ailments, etc. Further, significant developments are also being done in other sectors like electronics, agriculture, and energy.

In this report, the analysts have studied the current nano technology market on segment basis (by application, by component and by region), so as to provide an insight on the current market scenario as well as forecasts of the aforementioned segments till 2024. The report provides an in-depth analysis of all the major segments, taking into account the major developments taking place at global level in the respective segments that will further boost the growth of nanotechnology market.

Further, the application section covers the use of nanotechnology in electronics, energy, cosmetics, medical, defence, and food and agriculture sectors; while the component section covers the segregation of nanotechnology market into nano materials, nano tools, and nano devices.

This conference is focusing on all the major aspects in the fields of Nano technology. It would be beneficial for all the students and Researchers who ever willing to enter into corporate worlds targeting to the respective fields.

Be a part of it!!!

Conference Series LLC LTD invites all the participants from all over the world to attend “5th Annual Congress on Nano medicine and Drug Delivery during August 10-11, 2020 at Bangkok, Thailand Which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Asia Pacific Nano Congress welcomes all the Nano Technologists, Electronic Engineers, Researchers, Industrialists, Young Scientists as well as Student and Corporate delegates across the world to participate in the event and to have a great experience. The theme of the conference is based on “A Spectrum of Opportunities towards advancement on Nano science and Nano technology”. International symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Nano technology during the conference. We also welcome International Exhibitions form corporate sectors to showcase the recent advancements in the tools and techniques.

Sessions and Tracks

Sessions/Tracks

Track 1: Nanoparticles and Nano medicine

Nano medicine is a branch of medicine that applies the knowledge and tools of nanotechnology in the prevention and treatment of diseases. Nano medicine involves the use of nano scale materials, such as biocompatible nanoparticles and Nano robots, for diagnosis, delivery, sensing or actuation purposes in a living organism. Nanoparticles with ~100 nano meters have been widely used to improve the drug accumulation, internalization and therapeutic efficacy. The physicochemical and biological properties of the Nanoparticles can also be finely adjusted by tailoring their chemical properties, sizes, shapes, structures, morphologies, and surface properties. Nano medicine is the medical application of Nanotechnology. Nanotechnology has provided the possibility of delivering drugs to specific cells using nanoparticles. Current problems for nano medicine involve understanding the issues related to toxicity and environmental impact of nano scale materials.

Nano medicine seeks to deliver a valuable set of research tools and clinically useful devices in the near future. The National Nanotechnology Initiative expects new commercial applications in the pharmaceutical industry that may include advanced drug delivery systems, new therapies, and in vivo imaging.

Track 2: Pharmaceutical Nanotechnology

Pharmaceutical Nanotechnology based system deals with emerging new technologies for developing customized solutions for drug delivery systems. The drug delivery system positively impacts the rate of absorption, distribution, metabolism, and excretion of the drug or other related chemical substances in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptor’s signaling and activity. Pharmaceutical nanotechnology embraces applications of nano science to pharmacy as nano materials, and as devices like drug delivery, diagnostic, imaging and biosensor.

Track 3: The Evolution of Nano medicine with the Re-Evolution of  Nano technology

Nanotechnology seems to have gained a widespread interest in the recent years. Nanotechnology has considerably accelerated the growth of regenerative medicine the past few years. Application of Nanotechnology in regenerative medicine has revolutionized the designing of grafts and scaffolds which has resulted in new grafts/scaffold systems having significantly enhanced cellular and tissue regenerative properties. Since the cell–cell and cell-matrix interaction in biological systems takes place at the nano scale level, the application of nanotechnology gives an edge in modifying the cellular function and/or matrix function in a more desired way to mimic the native tissue/organ. Nano medicine introduces Nanotechnology concepts into medicine and thus joins two large cross disciplinary fields with an unprecedented societal and economical potential arising from the natural combination of specific achievements in the respective fields.

Track 4: Nano medicine and Nano biotechnology

Nanotechnology is universally recognized as one of the most important scientific fields of the twenty‐first century. Biomedical applications of this technology offer great promise in finding new approaches to repairing damaged tissues and curing disease. Nano medicine and Nano biotechnology will address key topics from the perspectives of medicine, biology, physics, chemistry, and engineering, and serve as an encyclopedic reference for Nano medicine and Nano biotechnology research.

Track 5: Nano robotics and Nano medicine

Nano medicine will be based on the ability to build Nano robots. In the future these Nano robots could actually be programmed to repair specific diseased cells, functioning in a similar way to antibodies in our natural healing processes. The motivation for the new manipulation technology is the desire to enter the micro- and Nano world not only by viewing but also acting, altering micro- and nano sized objects. A new era on medicine are expected to happen in the coming years. Due to the advances in the field of Nanotechnology, Nano device manufacturing has been growing gradually. The elimination of bacterial infections in a patient within minutes, instead of using treatment with antibiotics over a period of weeks.

Track 6: Smart Drug Delivery Technology

Some smart drug delivery platform is based on neutral phospholipid Nano liposomes. Where classic Classic liposomes modalities have had manufacturing problems involving sizing, uniformity, loading, storage, and enhancement compatibility, which can be overcome by employing true nanotechnology to build liposomes upon discrete self-assembling DNA scaffolds. The smart drug delivery system is used for delivering drugs to the host. Biological MEMS or NEMS technology based drug pumps, micro-pumps, micro-needles, micro-osmotic pumps, and information detected by biological sensors is analyzed and the drug delivery system is actuated to deliver the drug based on the information. nano-pumps are utilized for smarter drug delivery. One of the concerns these days about self-assembling nanotechnology is that it is so advanced beyond the current drug paradigm that it becomes problematic from a regulatory point of view. While there is currently no drug treatment delivered directly into these types of cancers.

Track 7: Computational Studies in Nanoparticles

The computational studies in nanoparticles have demonstrated that there has been considerable progress in Nano and biotechnology in the last several years. However, several key challenges have also become apparent, including the need for a better understanding of nanoparticle behaviour in vivo and the development of more effective nanoparticle therapeutics. Computational efforts are becoming an important tool in addressing both of these challenges, as well as in generally facilitating and accelerating nanotechnology-based translational research. The Nano informatics has come out as a new research area that covers raw data management, analysis of the data derived from biomedical applications and simulation of nanoparticle interactions with biological systems depicting the integration of biology, nanotechnology and informatics to form the basis for computational Nanomedicine.

Track 8: Research and Development of Nano medicine

Nano medicine has been developing rapidly in recent years, particularly in the development of novel Nano tools for medical diagnosis and treatment. For instance, a new trend is becoming prevalent in developing Nano systems for simultaneous tumour diagnosis and therapy. A new terminology "Theranostics" has been frequently used and applied in pre-clinical research and trials. A Nano system can simultaneously achieve both cell targeted in vivo imaging and photo thermal treatment of cancer. While achieving concurrent high spatial and temporal resolution of the lesions via cell targeting; special non-evasive treatments are implemented at the same time by various means, such as localized drug release, hyperthermia, and photo-thermal therapy. Inspired by these challenging problems in biomedical fields, the development of the nanotechnologies will be the key in addressing some of the critical issues in medicine, especially in early cancer diagnosis and treatment.

Track 9: Nanoparticles as Precise Drug Delivery Systems

With the remarkable development of Nanotechnology in recent years, new drug delivery approaches based on the state-of-the-art nanotechnology have been receiving significant attention. Nanoparticles, an evolvement of nanotechnology, are increasingly considered as a potential candidate to carry therapeutic agents safely into a targeted compartment in an organ, particular tissue or cell. These particles are colloidal structures with a diameter less than 1,000 nm, and therefore can penetrate through diminutive capillaries into the cell’s internal machinery. This innovative delivery technique might be a promising technology to meet the current challenges in drug delivery. The different types of nanoparticles drug delivery systems under investigation and their prospective therapeutic applications, and also present a closer look at the advances, current challenges, and future direction of nanoparticles drug delivery systems.

Track 10: Polymer Nanoparticles for Nano medicines

The use of nano scale materials and processes to address human disease is perhaps the most promising, considering that most complex downstream symptoms of disease are initiated by molecular level phenomena. Nano medicine is defined as biological and medical intervention at the nano meter scale for the treatment, diagnosis, and increased understanding of biology and disease. Tremendous advances in the area of polymer synthesis and self-assembly have given rise to a new toolbox of engineered nano sized delivery and diagnostic agents that permit systemic and local administration, circulation in the bloodstream, and uptake and diffusion at the cellular and subcellular level.

Track 11: Design and Characterization of Nano Drug Systems

Recent years have witnessed the rapid development of inorganic nano materials for medical applications. At present, nano medicines-nanoparticles (NPs) destined for therapy or diagnosis purposes-can be found in a number of medical applications, including therapeutics and diagnosis agents .Pushing the limits of nanotechnology towards enhanced Nano medicines will surely help to reduce side effects of traditional treatments and to achieve earlier diagnosis. The interplay between engineered nano materials and biological components is influenced by complex interactions which make predicting their biological fate and performance a nontrivial issue. We hope that both early-stage and experienced researchers will find it valuable for designing nanoparticles for enhanced bio-performance. Nano emulsions have attracted great attention in research, dosage form design and pharmacotherapy. This is as a result of a number of attributes peculiar to nano emulsions.

Track 12: Toxicology of Nanoparticles

Nanotechnology is a rapidly growing field having potential applications in many areas. Nanoparticles have been studied for cell toxicity, immune toxicity, and geno toxicity. Tetra zolium-based assays such as MTT, MTS, and WST-1 are used to determine cell viability. Different types of cell cultures, including cancer cell lines have been employed as in vitro toxicity models. Considering the potential applications of NPs in many fields and the growing apprehensions of FDA about the toxic potential of Nano products, it is the need of the hour to look for new internationally agreed, free of bias toxicological models by focusing more on in vivo studies. The rapid expansion of nanotechnology promises to have great benefits for society, yet there is increasing concern that human and environmental exposure to engineered nano materials may result in significant adverse effects. The system was developed for Nano toxicity assessment at single and multiple cell levels which can measure and compare the microscopic and macroscopic effects of nanoparticles interaction with cells, without interference from neighbouring cells' cues and also overall integrative effects produced by nanoparticles and cell–cell communication.

Track 13: Emerging Nano medicine

Currently, the treatment of HIV requires regular oral dosage of HIV drugs, and chronic oral dosing has significant complications that arise from the high pill burden experienced by many patients across populations with varying conditions leading to non-adherence to therapies. Recent evaluation of HIV patient groups have shown a willingness to switch to nano medicine alternatives if benefits can be shown. Research efforts by the Liverpool team have focused on the development of new oral therapies, using Solid Drug Nanoparticle (SDN) technology which can improve drug absorption into the body, reducing both the dose and the cost per dose and enabling existing healthcare budgets to treat more patients.

Track 14: Pharmaceutical Formulations

Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally administered drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect. Formulation studies also consider such factors as particle size, polymorphism, pH, and solubility, as all of these can influence bioavailability and hence the activity of a drug. The drug must be combined with inactive ingredients by a method which ensures that the quantity of drug present is consistent in each dosage unit e.g. each tablet. The dosage should have a uniform appearance, with an acceptable taste, tablet hardness, or capsule disintegration. By the time phase III clinical trials are reached, the formulation of the drug should have been developed to be close to the preparation that will ultimately be used in the market.

Track 15: Applied Pharmaceutical Science

Pharmacy is the science and technique of preparing and dispensing drugs. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. A theory relating chemical structure to pharmaceutical activity emerged from the interplay of experimental results from animal and human tests using vaccines, antitoxins, and antibodies with chemical knowledge about dyes and their molecular structures. Although pharmacology is essential to the study of pharmacy, it is not specific to pharmacy. Pharmaco informatics is considered as another new discipline, for systematic drug discovery and development with efficiency and safety. The progressively more important role of the chemist and chemical science in pharmaceuticals in the early-20th century is mirrored in the history of the American Chemical Society's Division of Medicinal Chemistry

Trck 16:  Pharmacokinetics & Pharmacodynamics

Pharmacokinetics is currently defined as the study of the time course of drug absorption, distribution, metabolism, and excretion. Clinical pharmacokinetics is the application of pharmacokinetic principles to the safe and effective therapeutic management of drugs in an individual patient. Primary goals of clinical pharmacokinetics and drug formulation include enhancing efficacy and decreasing toxicity of a patient’s drug therapy. The development of strong correlations between drug concentrations and their pharmacologic responses has enabled clinicians to apply pharmacokinetic principles to actual patient situations.

Pharmacodynamics refers to the relationship between drug concentration at the site of action and the resulting effect, including the time course and intensity of therapeutic and adverse effects. The effect of a drug present at the site of achievement is determined by that drug’s binding with a receptor. Receptors may be present on neurons in the central nervous system (i.e., opiate receptors) to depress pain sensation, on cardiac muscle to affect the intensity of contraction, or even within bacteria to disrupt maintenance of the bacterial cell wall

Track 16 :  Novel Drug Delivery System

Identifying drug targets plays essential roles in designing new drugs, drug formulations and combating diseases. Unfortunately, our current understanding about drug targets is far from comprehensive. Screening drug targets in the lab is an expensive and time-consuming procedure. In the past decade, the accumulation of various types of study of science related data makes it possible to develop computational approaches to predict drug targets. Non-communicable diseases such as cancer, atherosclerosis and diabetes are responsible for most important social and health affliction as millions of people are dying every year. Out of which, atherosclerosis is the leading cause of deaths worldwide. The lipid abnormality is one of the most important modifiable risk factors for atherosclerosis. Both genetic and environmental components are associated with the development of atherosclerotic plaques. Immune and inflammatory mediators have a complex role in the initiation and progression of atherosclerosis. Understanding of all these processes will help to invent a range of new biomarkers and novel treatment modalities targeting various cellular events in acute and chronic inflammation that are accountable for atherosclerosis. Several biochemical pathways, receptors and enzymes are involved in the development of atherosclerosis that would be possible targets for improving strategies for disease diagnosis and management.

Track 17 :  Business Opportunities in Drug Delivery

The global market for Business Development of Drug Delivery Technology in 2010 was $131.6 billion and is expected to rise at a compound annual growth rate (CAGR) of 5% and reach nearly $175.6 billion by 2016. The U.S constituted approximately 59% of the total drug delivery market in 2010 and was $78 billion. It is forecast to reach nearly $103 billion in 2016 at a CAGR of 4.7%. Europe contributed about 27% of the total drug delivery market in 2010 and was $36 billion and is expected to grow to $49 billion by 2016 at a CAGR of 5.6% in 2013, Drug Delivery Global market reached $150.3 billion, according to BCC research. This was an increase from $142 billion the previous year. Given its predicted annual growth the market represents a considerable business opportunity, which has been reflected in increasing number of drug delivery specialists. Consistent quality and competitive costs of product improves Production performance and continuity of supply and Product and technology auditing and due diligence with minimizing Regulatory Issues, drug formulation, quality control, and business development Business opportunities in drug delivery.

Track 18 :  Clinical Trails & Bio therapeutics

Clinical Bio therapeutic aspects including study drug formulations, drug design, drug-drug interactions, QT assessment, immunogenicity, comparability, special populations (hepatic and liver failure), PK and PD, regulatory expectations of PK and PD characterization, as well as reviewing factors which influence the ADME of Bio therapeutics. The objectives of early clinical development of therapeutic proteins are the same as for small molecules i.e. to investigate the molecule in a manner that will gain necessary knowledge about its tolerability safety pharmacokinetics (PK) and if possible pharmacodynamics (PD) effects in the most appropriate human populations while simultaneously protecting their safety. However, there are specific features of proteins that must be considered when designing clinical pharmacology studies.

Market Analysis

 It is forecasted that the total market size of Nano medicine and Advanced Drug Delivery would be $755.3 billion with a 60/40 split between Nano medicine and advanced drug delivery respectively, although developing new targeted delivery mechanisms may allow more value to be created for companies and entrepreneurs.

Nano medicine and drug delivery can address one of the greatest difficulties in the post-genomic time of the 21st century – making the essential associations amongst Academics and industry professional.

To address these difficulties, the field of Nano medicine and advanced drug delivery has experienced exponential development amid the last 5 years. Innovations, for example, Personalized Nano medicine, Design of Nano drugs, Drug targeting and design, Routes of drug administration, Novel and Smart drug delivery system, Regenerative Medicine and Tissue Engineering, Nanotechnology and Biomedical applications, Nanomaterial’s for Drug Delivery, Regulatory Aspects Towards Approval of Nano medicine, Application of nanotechnology for treatment of cancer etc., Nano Pharmaceutical Industry and Market processing and drug delivery guarantee to change the world of Nano pharmaceutics and advanced drug delivery system much similar way that integrated and changed the world of pharmaceutical sciences.

There is a strong market for Nano pharmaceutics and drug delivery in Europe. The pharmaceutical business in Ireland is profoundly best in class, incorporating the most recent innovation, cutting edge equipment and strict quality control methodology. Ireland's pharmaceutical industry offers an extensive variety of items and services, from research and development for new medicines to the manufacturing and marketing of new medicines for humans and animals. Around 120 abroad organizations have plants in Ireland including 9 of the 10 biggest pharmaceutical organizations on the planet. The pharmaceutical business is generally new to the Irish economy. A large portion of the organizations working around there have just had nearness in Ireland since the 1960s.

The Pharmaceutical sector had 46.9% growth which is the second biggest percentage increase in NSV in Ireland between the years 2013 – 2016. The most significant increase in Net Selling Value was in the Pharmaceutical sector. The value of Basic pharmaceutical products and preparations increased by 18.2% from €36.1 billion in 2014 to €42.6 billion in 2015. The global drug delivery technology market is projected to reach USD 1,669.40 Billion by 2021 from USD 1,179.20 Billion in 2016, at a CAGR of 7.2% during the forecast period. This market is segmented based on route of administration, facility of use, and region. The global nanotechnology drug delivery market was valued at US$ 41,062.5 Mn in 2014 and is projected to reach US$ 118,527.2 Mn by 2023, expanding at a CAGR of 12.5% from 2015 to 2023.

Exhibition:

Why exhibit?

•           Make sales

•           Debut new product

•           Profile your brand

•           Meet new business partners and suppliers

•           Develop key relationships and Educate healthcare

•           Pharma and biotech institutions and academia.

Who you will meet?

Chance to meet Leaders in

•           Drug Delivery

•           Formulation

•           Drug Development

•           Nanotechnology

•           QbD

•           Delivery Devices

•           Bioavailability

•           New Products

•           Pre-Formulation

•           Process R&D

•           CMC

•           Stability

•           Bio manufacturing

•           Manufacturing

•           Solid State Chemistry

•           Analytical Development

•           Product Enhancement

Who should sponsor?

•           Analytical Services

•           Formulation Development

•           CMO

•           Drug Delivery Technologies

•           Full service CRO

•           Preformulation testing

•           Software

Why you should attend?

•           Get to the heart of why formulation and delivery strategies fail. Dissect the challenges before looking for concrete solutions.

•           Discover how advances in the sector are impacting both large and small molecule drugs.

•           Explore tried and tested routes to improve bioavailability.

•           Understand how to develop the right formulation and delivery strategy with a strong scientific, clinical and commercial mind set.

•           Discover the latest innovations in drug delivery devices.

•           Be inspired by innovative case studies and realise the potential impact on your formulation or delivery processes.

•           Engage in the exciting event format, with round tables, panels, showcases, speed networking and multiple conference tracks.

•           Share experiences, insights and strategies in interactive peer-to peer round tables.

•           Hear more perspectives in one place – from large medium and small organisations from pharma, biotech and academia.

•           Discover how scientific formulation advancements are being implemented in practice.

•           Get to the heart of why formulation and delivery strategies fail. Dissect the challenges before looking for concrete solutions.